IDEAS home Printed from https://ideas.repec.org/a/dbk/procee/v3y2025ip1056294piii2025566id1056294piii2025566.html
   My bibliography  Save this article

Fecal microbiota transplantation (FMT) versus conventional treatment in Clostridioides difficile antibiotic-associated diarrhea

Author

Listed:
  • Juliana Stupnik
  • Gerardo Laube

Abstract

Introduction: Antibiotic-associated diarrhea (AAD) is a common side effect resulting from altered intestinal flora, allowing the proliferation of pathogens such as Clostridioides difficile. This bacterium is responsible for pseudomembranous colitis, an increasing hospital-acquired disease related to antibiotic use and more virulent strains. Treatment of C. difficile colitis requires discontinuation of the antibiotics that trigger the infection, as the use of additional antimicrobials can be detrimental, especially in patients with multiple comorbidities. Fecal microbiota transplantation (FMT) has been positioned as a promising treatment for C. difficile colitis by restoring microbial diversity in the colon, eliminating the bacteria and reducing recurrence rates. systematic review of observational, descriptive and retrospective scientific papers published between 2018 and 2024, with the aim of evaluating the effectiveness of fecal microbiota transplantation versus refractory antibiotic treatment in cases of pseudomembranous colitis due to Clostridioides difficile. Of the 10 articles used to prepare the trial, the results of 4 of them were compared. The data reveal a greater efficacy of TMF in Clostridioides difficile colitis against conventional treatment, demonstrating a decrease in adverse effects and mortality rate, greater efficacy and lower disease recurrence. Fecal microbiota transplantation (FMT) is a superior treatment to antibiotics for Clostridioides difficile colitis, as it restores the microbial diversity of the intestine, eliminating the infection and preventing recurrences. Unlike antibiotics, which can cause dysbiosis and increase the risk of relapse, TMF shows higher success rates and is especially beneficial for patients with comorbidities. Although its initial cost is higher, the long-term savings from fewer hospitalizations and relapses make it a more cost-effective option.

Suggested Citation

Handle: RePEc:dbk:procee:v:3:y:2025:i::p:1056294piii2025566:id:1056294piii2025566
as

Download full text from publisher

To our knowledge, this item is not available for download. To find whether it is available, there are three options:
1. Check below whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a
for a similarly titled item that would be available.

More about this item

Statistics

Access and download statistics

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:dbk:procee:v:3:y:2025:i::p:1056294piii2025566:id:1056294piii2025566. See general information about how to correct material in RePEc.

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

We have no bibliographic references for this item. You can help adding them by using this form .

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Javier Gonzalez-Argote (email available below). General contact details of provider: https://proceedings.ageditor.ar/ .

Please note that corrections may take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.